Introduction
============

In recent years, unsedated transnasal esophago-gastro-duodenoscopy (UT-EGD) has been used for diagnostic [@JR223-1] [@JR223-2] and therapeutic purposes such as percutaneous endoscopic gastrostomy [@JR223-3], enteral tube placement [@JR223-4], nasobiliary tube drainage [@JR223-5] [@JR223-6] and polypectomy [@JR223-7]. The satisfactory safety and tolerance profiles make UT-EGD an alternative to peroral conventional EGD with or without sedation [@JR223-1] [@JR223-8]. There is a trend toward performing transnasal laryngoscopy [@JR223-9], transnasal esophagoscopy [@JR223-10] (especially for screening Barrett\'s esophagus [@JR223-2] [@JR223-10] [@JR223-11]), and UT-EGD in the office [@JR223-11] [@JR223-12]. However, many techniques related to UT-EGD are not standardized [@JR223-13]. One important step, the selection of the optimal meatus insertion route for UT-EGD, has not been explored.

The sniff test is a subjective way to select a nostril insertion site for nasal anesthesia [@JR223-11] [@JR223-12] [@JR223-13] [@JR223-14] [@JR223-15] [@JR223-16]. A nostril insertion site is not the final meatus insertion route, which is at the endoscopist's discretion. A wrongly selected meatus insertion route may cause insertion failure, nasal pain, nasomucosal injury, or epistaxis [@JR223-14] [@JR223-15] [@JR223-16] [@JR223-17]. Yet there is no study to evaluate the reliability of a sniff test before these transnasal endoscopic procedures. The idea that "looking to select" is better than " sniffing to select" emerged from our study 7 years ago [@JR223-14]. We have previously described *endoscopic-guided aerosolized spray* for nasal anesthesia before UT-EGD; with an ultrathin transnasal endoscope, the endoscopist searched for the most patent nasal meatus from both sides before applying aerosolized sprays of lidocaine [@JR223-14] [@JR223-15]. To establish a simple *endoscopic meatus scoring scale* (EMSS), we have further devised a new concept, anterior meatuscopy, to compare nasal meatus patency scores for each side of the nasal cavity.

Mori et al reported that in their transnasal endoscopic examinations of 1,569 patients, 78 % of nasal bleeding sites were in the middle nasal turbinate (MNT), 15 % in the inferior nasal turbinate (INT), and 6 % in the nasal septum [@JR223-18]. Their data suggest that the middle nasal meatus (MNM) is the most frequently used tract but the inferior nasal meatus (INM) and common nasal meatus (CNM) are uncommon routes for nasal insertion in Japan. In fact the CNM, which is between the nasal septum and medial walls of the MNT and INT, is neglected by endoscopists. Ignorance of the CNM is particularly common in endoscopists who are unfamiliar with UT-EGD.

We hypothesized that the CNM, if detected by anterior meatuscopy, was a safer route than the MNM or the INM for avoiding the most common adverse effects of UT-EGD, including epistaxis, nasal pain and nasal discharge [@JR223-14] [@JR223-15] [@JR223-16]. Thus, using the transnasal endoscope at hand as a meatuscope, we evaluated patency scores of the nasal meatuses before transnasal endoscopy. We compared the results with the reliability of the sniff test, which has been used for decades. More importantly, we compared the adverse effects of passing through the CNM versus an equally patent MNM and INM.

Patients and methods
====================

All 1,000 consecutive outpatients with dyspeptic symptoms underwent both a sniff test and an anterior meatuscopy before UT-EGD to obtain their respective EMSS. The study was conducted at Buddhist Tzu Chi Hospital between 2011 and 2014, employing an EG530N5 endoscope (Fujinon, Tokyo, Japan). Patients who had prior nasal trauma or surgery, recent or present upper gastrointestinal bleeding, and who were unable to answer questions were excluded from this study. Patients who were allergic to any anesthetic agents were not recruited.

Sniff test
----------

Instead of the conventional left lateral decubitus position, all patients sat upright in an examination bed. The more patent nostril was selected by the patient inhaling through only one nostril with the other sealed by the examiner's index ﬁnger [@JR223-14].

Anterior meatuscopy
-------------------

We have developed an endoscopic method that allow us to look for the optimal meatus insertion route in just seconds. When placed in the anterior nasal cavity, a transnasal endoscope itself can act as a nasoscope (or more precisely a meatuscope) to compare insertability and patencies of the INM, CNM and MNM. Anterior rhinoscopy examines the mucosa and anatomical pathology inside the anterior nasal cavity. In contrast, anterior meatuscopy is simple to perform, accurate for selection of the most patent nasal meatus, and appropriate for all kinds of patients. With anterior meatuscopy, the characteristics of the CNM, INM, and MNM can be more clearly elucidated.

### The CNM versus the MNM/INM

The CNM is the space between the nasal septum and "medial" sides of the MNT and INT. In contrast, the routes of the INM or the MNM are along the "inferior" aspects of their corresponding turbinates ([Fig. 1a](#FI223-1){ref-type="fig"}). The CNM at the MNT height (CNM-*MNT level*) is usually too narrow to permit passage of a transnasal endoscope ([Fig. 1](#FI223-1){ref-type="fig"}). Compared with the CNM-*MNT level*, the CNM at the INT height level (CNM-*INT level*) is wide enough for transnasal endoscope insertion and exertion ([Fig. 1](#FI223-1){ref-type="fig"} and [Fig. 2 d](#FI223-2){ref-type="fig"}). Thus, in clinical practice, both the anterior and posterior CNMs actually refer to the CNM-*INT level*.

![ The common nasal meatus is the route of choice. (**a**) The commonly recognized meatus for nasal insertion is the INM (1) or the MNM (2). Usually the CNM at the INT level (CNM-*INT,*✓) is wider than that at the MNT level (CNM-*MNT*). When passing through the INM, MNM, CNM-*MNT level* or between the CNM-*INT* and CNM-*MNT* (Cb), the endoscope (black circles) may induce mucosal injury or epistaxis (**X)** through contact with the MNT and/or INT (red **X)** or the nasal septum (black **X)**. (**b**) Endoscopic view showing that insertion through the CNM-*INT level* (right nasal cavity) is the safest route (✓). (**c**) In the same patient, the nasal septum deviation (arrow) nearly completely obstructs the proximal MNM and only the CNM-*INT* (left nasal cavity) is patent enough for insertion (✓). (**d**) In another patient, a nasal septal spur (arrow) completely obstructs the distal MNM and only the CNM-*INT*(right nasal cavity) is patent enough for insertion (✓). The dotted lines in (**b**), (**c**) and (**d**) represent routes that are too narrow for transnasal insertion.](10-1055-s-0034-1392772-i223ei1){#FI223-1}

![ EMSS of the INM (right). The INM is the space between the inferior aspect of the *INT* and the nasal floor (*NF*). (**a**) grade 0: no space; (**b**) grade I: only up-sloping INT border (black arrow) and slit-like distant INM are seen; (**c**) grade II: (i) the up-sloping/down-sloping INT border (the curved endoscope) and transition angle (\*) plus (ii) the incomplete choana (dotted line) are seen; a nasal septum (NS) spur (arrow) abutting against the posterior MNM; (**d**) grade III: (i) the posterior insertion of the INT (PI-*INT*, arrow), (ii) the PI-*MNT* (arrowhead) and (iii) the complete choana (dotted circle) are seen. In contrast to the scope in (**c**) through the INM, the scope in (**d**) is along the CNM at the INT level.](10-1055-s-0034-1392772-i223ei2){#FI223-2}

### The MNM versus the INM

In the nasal cavity, the anterior head of the INT is more anterior than the anterior head of the MNT ([Fig. 3 c](#FI223-3){ref-type="fig"}). Sometimes, the anterior head of the INT is hypertrophic to some extent, preventing approach to the inner MNM. Therefore, the *anterior CNM-INT level* (herein below simply denoted as *anterior CNM*) is the only gateway for entry to the*atrium of the MNM* ([Fig. 3 c](#FI223-3){ref-type="fig"} and [Fig. 3 d](#FI223-3){ref-type="fig"}), which is the anterior expanded portion of the MNM just above the nasal vestibule. More specifically, the actual pass-by sites of a transnasal endoscope to the MNM comprise the "CNM-atrium-MNM" structures, constituting a straightforward route ([Fig. 3 c](#FI223-3){ref-type="fig"} and [Fig. 4 c](#FI223-4){ref-type="fig"}). However, endoscopic insertion through the MNM route is most commonly hindered when the INT and the nasal septum abut each other, forming an "endoscope clamp" ([Fig. 4c](#FI223-4){ref-type="fig"}, arrows). Conversely, the endoscopic pathway of the INM is along the curved inferior surface of the INT ([Fig. 2 c](#FI223-2){ref-type="fig"}) without the need to go through the *anterior CNM* ([Fig. 3 c](#FI223-3){ref-type="fig"}). With either the INM or the MNM route, the up-down angulation movement of the scope tends to cause epistaxis in the inferior surface of the INT or the MNT.

![ EMSS of the anterior CNM (right). The anterior CNM is the space between the anterior head of the INT (AH-INT) and the NS. (**a**) grade 0: no space; (**b**) grade I: slit-like; (**c**) grade II: although the anterior head of the MNT (AH-MNT) is seen, the scope in the anterior CNM cannot reach the*atrium of the MNM* (dotted line region) because of scope resistance and/or nasal discomfort. Thus, with a grade II anterior CNM, EMSS of the inner MNM is regarded as not evaluable; (**d**) grade III: the scope can reach the atrium of the MNM without scope resistance and/or nasal discomfort. Usually the whole AH-MNT is seen in a grade III anterior CNM. In contrast to the scope in (**c**) targeting the MNM, the scope in (**d**) is along the CNM at the INT level.](10-1055-s-0034-1392772-i223ei3){#FI223-3}

![ EMSS of the MNM (right). The MNM is a canal situated between the *MNT* and the *INT*. (**a**) grade 0: no space; (**b**) grade I: slit-like distant MNM is seen; a septal spur (arrow) further narrows the MNM; (**c**) grade II: (i) the whole MNT and (ii) the incomplete choana (dotted line) are seen; further approach is prevented by scope resistance and/or nasal discomfort. An "endoscopic clamp" is formed by the INT and the nasal septum. The scope in (**c**) is along the inferior surface of the MNT; (**d**) grade III: (i) the posterior insertion of the MNT (PI-*MNT*, arrowhead), (ii) the PI-*INT* (arrow) and (iii) the complete choana (dotted circle) are seen.](10-1055-s-0034-1392772-i223ei4){#FI223-4}

### The safest tunnel

A safe CNM should demonstrate patency anteriorly and posteriorly on endoscopy. Given such a spacious CNM, the up-down angulation movements of an endoscope tip would be less likely to cause injury to the INT or the MNT. Therefore, the anterior-to-posterior CNM, if endoscopically patent enough, was hypothesized to be the "safest tunnel" for trans-meatal passage (the scope route shown in [Fig. 2 d](#FI223-2){ref-type="fig"}). In this study, we defined patency scores for the anterior meatuses but not for the posterior ones because anterior meatuscopy principally observes the anterior nasal cavity. We defined an endoscopically patent *anterior CNM* (a grade III *anterior CNM*), which allows the scope to be inserted to the *atrium of the MNM*. The *posterior CNM* was not defined or evaluated with anterior meatuscopy. Instead, an endoscopically patent *posterior CNM* was always available in a grade III INM, which was spacious enough to visualize both the posterior insertions of the MNT and INM (see the definition below) during anterior meatuscopy.

### Meatus selection principle for UT-EGD

We inserted the scope through the "safest tunnel" (a grade III anterior-to-posterior CNM) of the nasal cavity as the first priority ([Fig. 2 d](#FI223-2){ref-type="fig"} and [Fig. 3 d](#FI223-3){ref-type="fig"}). We hypothesized that passing through this route would avoid injury to the INT or the MNT, which are the most common sites of epistaxis during transnasal endoscopy [@JR223-20]. If this grade III anterior-to-posterior CNM route was not identified, the meatus with only a grade III INM or a grade III MNM was selected as a second choice.

Fewer patients had MNM evaluated with EMSS than INM or *anterior CNM* because the procedure is dependent upon grade III *anterior CNMs*. Thus all of the patients with MNM evaluable with EMSS were eligible for transnasal insertion and exertion. Adverse effects also were compared for patients undergoing endoscopy through a less than grade III MNM versus a less than grade III INM.

### Three passes in anterior meatuscopy

Three endoscopic passes with anterior meatuscopy were performed on each side of the nasal cavity without the need for any local anesthetics or decongestant ([Video 1](#ME223-1){ref-type="media"}).

**Video 1** The author, Dr. C. Hu is demonstrating transnasal meatuscopy is more accurate than a sniff test to select a nostrile insertion route.

#### First pass (for the INM)

The scope was inserted a little behind the nasal vestibule, flexed downward, and gently passed along the INM until scope resistance and/or nasal discomfort was encountered. The far end of the posterior INM was usually inaccessible without decongestive anesthesia.

#### Second pass (for the anterior CNM)

After observing the INM in the first pass, the endoscopist withdrew the scope to the anterior head of the INT, re-straightened the scope to view the entrance of the*anterior CNM,* and gently inserted the scope to the *atrium of the MNM* until scope resistance and/or nasal discomfort was encountered.

#### Third pass (for the MNM)

The MNM was evaluable when the scope could be inserted to the *atrium of the MNM* without scope resistance and/or nasal discomfort. In the*atrium of the MNM*, the endoscopist reflexed the scope downward and gently passed it along the inferior border of the MNT towards the posterior MNM until scope resistance and/or nasal discomfort was encountered.

### Endoscopic meatus scoring scale

During anterior meatuscopy, we used a simple endoscopic meatus scoring scale (EMSS) to define patencies of the INM, CNM, and MNM. A grade III meatus was defined as endoscopically patent. The definitions of each EMSS were defined as follows:

### EMSS of the INM

*The INM is the space between the inferior aspect of the INT and nasal floor* (INT/NF: the "/" represents INM): grade 0: no space ([Fig. 2 a](#FI223-2){ref-type="fig"}); grade I: only up-sloping INT border (black arrow) and slit-like distant INM were seen ([Fig. 2 b](#FI223-2){ref-type="fig"}); grade II: (i) the complete upsloping-downsloping INT border (curved scope route) with the transition angle (\*) and (ii) the incomplete choana (dotted line) were seen; a nasal septum (NS) spur (arrow) abutting against the posterior MNM ([Fig. 2 c](#FI223-2){ref-type="fig"}); grade III: (i) the posterior insertion of the INT (PI-INT, arrow), (ii) the PI-MNT (arrowhead) and (iii) the complete choana (dotted circle) were seen ([Fig. 2 d](#FI223-2){ref-type="fig"}).

### EMSS of the anterior CNM

*The anterior CNM is the space between the NS and anterior head of the INT (AH-INT)*(NS-INT: the "-" represents CNM): grade 0: no space ([Fig. 3 a](#FI223-3){ref-type="fig"}); grade I: slit-like ([Fig. 3 b](#FI223-3){ref-type="fig"}); grade II: (i) although the anterior head of the MNT (AH-MNT) was seen, the scope could not reach the *atrium of the MNM* (dotted line region) due to scope resistance and/or nasal discomfort ([Fig. 3 c](#FI223-3){ref-type="fig"}). Thus, with a grade II anterior CNM, EMSS of the inner MNM was regarded as not evaluable; grade III: the scope could reach the *atrium of the MNM* without scope resistance and/or nasal discomfort. Usually the whole AH-MNT was seen in a grade III anterior CNM ([Fig. 3 d](#FI223-3){ref-type="fig"}).

### EMSS of the MNM

*The MNM is a canal situated between the MNT and the INT*(MNT/INT: the "/" represents MNM): grade 0: no space ([Fig. 4 a](#FI223-4){ref-type="fig"}); grade I: a slit-like posterior MNM was seen; a septal spur further narrowed the MNM ([Fig. 4 b](#FI223-4){ref-type="fig"}, arrow); grade II: (i) the whole MNT and (ii) the incomplete choana (dotted line) were seen; further approach was/were prevented by scope resistance or/and nasal discomfort ([Fig. 4 c](#FI223-4){ref-type="fig"}); grade III: (i) the posterior insertion of the MNT (PI-MNT, arrowhead), (ii) the PI-INT (arrow) and (iii) the complete choana (dotted circle) were seen ([Fig. 4 d](#FI223-4){ref-type="fig"}).

### Mnemonics for grading the three meatuses

The mnemonic for using this four-grade scale for each meatus was easily remembered: (a) grade "0" indicated a meatus had N"O" visible space; (b) grade "I" indicated a meatus was SL"I"T-like in width; (c) grade "II" indicated a meatus was about the width of a transnasal T"II"BE (i. e. endoscopic tube ≧ meatus, scope not smoothly insertable), (d) grade "III" indicated the width of a meatus was more than that of a transnasal T"II"BE (i. e. endoscopic tube \< meatus, scope smoothly insertable). Thus, a grade II meatus prevented the transnasal endoscope from entering the posterior meatuses due to scope resistance and/or nasal discomfort.

Nasal anesthesia
----------------

Gauze pledgetting was used to administer nasal anesthesia to all patients, in a 4:1 mixture of 4 % lidocaine and 1:1000 epinephrine for decongestion as previously described [@JR223-15]. During anterior meatuscopy, no local anesthetics were needed.

Transnasal endoscopy
--------------------

Five minutes after decongestive anesthesia was administered, all patients underwent transnasal endoscopy administered by one experienced transnasal endoscopist (Doctor C. Hu) to avoid inter-endoscopist bias. All of the meatus insertion routes were selected according to the results of each patient's anterior meatuscopy. As mentioned above, one of the three routes including (i) INM ([Fig. 2 c](#FI223-2){ref-type="fig"}), (ii) anterior-to-posterior CNM ([Fig. 2 d](#FI223-2){ref-type="fig"}), and (iii) CNM-atrium-MNM ([Fig. 3 c](#FI223-3){ref-type="fig"} and [Fig. 4 c](#FI223-4){ref-type="fig"}) was chosen according to the meatus selection principle to compare the adverse effects elicited during endoscopic passage through these three routes.

Statistical analysis
--------------------

Descriptive statistics were used. The sensitivity, speciﬁcity, positive predictive value (PPV), negative predictive value (NPV) and accuracy of a sniff test to predict the more patent nostril were calculated using the results of anterior meatuscopy coupled with EMSS as the gold standard. A chi-square test was used to analyze the equivalence for ordinal variables. A *P* value \< 0.05 was considered signiﬁcant. Analyses were performed using SPSS 12.0.1C (SPSS Inc., Chicago, IL, USA).

Results
=======

Patient characteristics
-----------------------

Using anterior meatuscopy to select the most patent meatus for nasal anesthesia and insertion, we were able to complete UT-EGD in all 1,000 cases (467 male and 533 female; mean age 54.9 years, range 19 -- 92 years) without insertion failure.

EMSS frequency distributions
----------------------------

The EMSS frequencies of the three nasal meatuses in both sides (right *vs*. left) of the nasal cavity were compared. In the INM (grade I: 653 *vs*. 834, *P* \< 0.001; grade II: 231 *vs*. 50, *P* \< 0.001), anterior CNM (grade III: 82 *vs*. 10, *P* = 0.04), and MNM (grade I: 57 *vs*. 5, *P* \< 0.05; grade II: 16 *vs*. 2, *P* = 0.007) significant differences were found between the EMSS frequencies on the right and left sides. Taking the right and left sides together, in the INM (grade I, n = 1487 \> grade II, n = 281 \> grade III, n = 137 \> grade 0, n = 95) and MNM (grade I, n = 62 \> grade II, n = 18 \> grade III, n = 11 \> grade 0, n = 1), the EMSS frequencies were both on the order of grade I \> II \> III \> 0. For the anterior CNM (grade II, n = 1099 \> grade I, n = 689 \> grade 0, n = 120 \> grade III, n = 92), the EMSS frequencies were on the order of grade II \> I \> 0 \> III ([Fig. 5](#FI223-5){ref-type="fig"}).

![ EMSS frequencies of the nasal meatuses. G = grade, R = right, L = left.](10-1055-s-0034-1392772-i223ei5){#FI223-5}

Sniff test was not reliable
---------------------------

With a sniff test, a patient might mistakenly select the right nose, whereas the EMSS could confirm that the left meatuses were more patent than the right ones ([Video 1](#ME223-1){ref-type="media"} and [Fig. 6](#FI223-6){ref-type="fig"}), and vice versa. Using EMSS as the gold standard, we found that a sniff test was not reliable, given its low sensitivity (63.3 %), specificity (67.3 %), PPV (69.1 %), NPV (61.4 %), and accuracy (65.2 %). With anterior meatuscopy, 320.7 out of 1,000 cases (32.1 %) were redirected to use the left nostril when a sniff test falsely directed the endoscopist to use the right nostril. Similarly, 360.6 out of 1,000 cases (36.1 %) were redirected to use the right nostril when a sniff test wrongly directed the endoscopist to use the left nostril ([Table 1](#TB223-1){ref-type="table"}).

![ omparison of the EMSS of both nasal cavities. On the right side: (A1) the INM is grade 0; (A2) the anterior CNM is grade II; (A3) the atrium (dotted-line regions from A2 to A3) is not approachable because of resistance to further scope insertion (white arrows from A2 to A3). Thus the EMSS of the inner MNM is regarded as not evaluable. On the left side: (B1) the INM is grade I; (B2) the atrium is approachable and thus the anterior CNM is grade III; (B3) the MNM is grade I. Compared with the right side (0, II, not evaluable), the left nasal meatuses (I, III, I) should be chosen for nasal anesthesia and endoscopic insertion.](10-1055-s-0034-1392772-i223ei6){#FI223-6}

###### Sensitivity, specificity, PPV, and NPV of sniff test.

  -------------------------------------------------------------------- ----------------------------------------- -------------------------- ----------------------
                                                                       **Anterior meatuscopy (gold standard)**                              
                                                                       Right side more patent                    Left side more patent      
  Right side more patent                                               339 (TP)                                  152 (FP)                   ***PPV*** 69.1 %
  **Sniff test**                                                                                                                            
  Left side more patent                                                196 (FN)                                  313 (TN)                   ***NPV***61.4 %
                                                                       ***Sensitivity***63.30 %                  ***Specificity***67.30 %   ***Accuracy***65.2 %
  Note 1: False-positive rate = FP/FP + TN = 152 /152 + 313 = 32.7 %                                                                        
  Note 2: False-negative rate = FN/FN + TP = 196 /196 + 339 = 36.6 %                                                                        
  -------------------------------------------------------------------- ----------------------------------------- -------------------------- ----------------------

PPV, positive predictive value; NPV, negative predictive value; TP, true positive; FP, false positive; FN, false negative; TN, true negative

The CNM was endoscopically patent only in about 10 % of cases
-------------------------------------------------------------

To fulfill the criterion of an endoscopically patent CNM at the INT level, EMSS for both the anterior CNM and the INM should be grade III. Accordingly, 137 cases had grade III INM and 92 cases had grade III anterior CNM ([Fig. 5](#FI223-5){ref-type="fig"}). In all 92 cases with a grade III anterior CNM, the INM was simultaneously grade III. Thus, 9.2 % (92 /1,000) of our patients had spacious anterior-to-posterior CNMs being used for endoscopic insertion and exertion. In contrast, 90.8 % (908 /1,000) of our patients received nasal insertion via the INM or the MNM.

### Passing through the CNM, if endoscopically patent, reduced complications

Adverse effects were compared for the 92 patients (with a grade III anterior-to-posterior CNM), the 45 (137 -- 92) with only a grade III INM, and the 11 patients with only a grade III MNM. Passing through the CNM versus the INM and the CNM versus the MNM produced marginal differences in reduction of epistaxis (*P* = 0.058 and *P* = 0.02, respectively), but the rates of nasal pain (*P* = 0.006 and *P* \< 0.001) and nasal discharge (*P* = 0.009 and *P* \< 0.001, respectively) were significantly decreased. Most importantly, adoption of the anterior-to-posterior grade III CNM was associated with complete freedom from epistaxis (n = 0) and nasal pain (n = 0). However, endoscopic passage through the INM rather than the MNM with equivalent grade III patency scores was associated with a trend toward reduction in total adverse effects but the difference did not rise to statistical significance (*P* = 0.05). However, compared with patients with grade 0-II INMs, those with grade 0-II MNMs for transnasal passage had significantly more adverse effects overall (*P* = 0.005) ([Table 2](#TB223-2){ref-type="table"}).

###### Comparison of transnasal adverse effects with insertion through different meatuses.

  ----------------------------------------------------------------------------------------------------------
                        Grade III (n = 92)\          Grade III (n = 45)\         *P* value (95 % CI)
                        CNM, n (%)                   INM only, n (%)             
  --------------------- ---------------------------- --------------------------- ---------------------------
  **Epistaxis**         0                            3 (6.7)                     0.058 (-0.6 -- 14.0)

  **Nasal pain**        0                            5 (11.1)                    0.006 (1.9 -- 20.3)

  **Nasal discharge**   3 (3.3)                      8 (17.8)                    0.009 (2.7 -- 26.3)

  **Total**             3.3 %                        35.6 %                       \< 0.0001 (17.8 -- 46.8)

                        **Grade III (N = 92)**\      **Grade III (N = 11)**\     ***P* value (95 % CI)**
                        **CNM, n (%)**               **MNM only, n (%)**         

  **Epistaxis**         0                            1 (9.1)                     0.02 (0.7 -- 17.5)

  **Nasal Pain**        0                            3 (27.3)                     \< 0.001 (0.9 -- 53.6)

  **Nasal discharge**   3 (3.3)                      4 (36.4)                     \< 0.001 (22.3 -- 50.5)

  **Total**             3.3 %                        72.8 %                       \< 0.0001 (56.0 -- 83.0)

                        **Grade III (N = 45)**\      **Grade III (N = 11)**\     ***P* value (95 % CI)**
                        **INM only, n (%)**          **MNM only, n (%)**         

  **Epistaxis**         3 (6.7)                      1 (9.1)                     0.71 (-16.1 -- 20.9)

  **Nasal Pain**        5 (11.1)                     3 (27.3)                    0.37 (-11.7 -- 44.1)

  **Nasal discharge**   8 (17.8)                     4 (36.4)                    0.45 (-11.9 -- 49.2)

  **Total**             35.6 %                       72.8 %                      0.05 (7.4 -- 66.9)

                        **Grade 0\~II (N = 771)**\   **Grade 0\~II (N = 81)**\   ***P* value (95 % CI)**
                        **INM, n (%)**               **MNM, n (%)**              

  **Epistaxis**         74 (9.6)                     9 (11.1)                    0.81 (-5.7 -- 8.7)

  **Nasal Pain**        278 (36.1)                   34 (41.9)                   0.36 (-5.5 -- 17.1)

  **Nasal discharge**   308 (39.9)                   36 (44.4)                   0.51 (-6.9 -- 15.9)

  **Total**             85.6 %                       97.4 %                      0.005 (7.5 -- 16.1)
  ----------------------------------------------------------------------------------------------------------

CNM, common nasal meatus; INM, inferior nasal meatus; MNM, middle nasal meatus

Discussion
==========

This study confirmed that anterior meatuscopy is more reliable than a sniff test for predicting nasal patency before UT-EGD. By comparing grading scales between the right and left meatuses, a transnasal endoscopist can be confident in applying nasal anesthesia and inserting to the meatus of choice while minimizing complications. We proposed reporting the how, where, and grading of nasomucosal injury after transnasal endoscopy and emphasized that a grading scale for defining insertion difficulty through a nasal meatus is important because it may be correlated with the severity of nasomucosal injury and bleeding [@JR223-16]. Since making those recommendations, we have been advocating anterior meatuscopy to compare meatus patency on both sides of the nasal cavity. Although the nasal cavity is a complex compartment, we used simple anatomical landmarks, patient feedback, and endoscope resistance to define EMSS (grade 0, I, II, and III). To our knowledge, this is the first endoscopic method studied for assessing meatus patency before UT-EGD.

Given that a sniff test is not only unreliable but also cannot be performed in patients who are unable to sniff, anterior meatuscopy is an attractive alternative. Using anterior meatuscopy, we revealed that the anterior INM is broader than the posterior INM, whereas the anterior MNM is narrower than the posterior MNM; these endoscopic observations are compatible with a cadaveric anatomical study [@JR223-19]. We have also found that the anterior CNM is narrower than the posterior CNM, which is also consistent with an anatomical study demonstrating that the INT bone is thicker anteriorly than posteriorly [@JR223-20].

With anterior meatuscopy, we have revealed that the INT has a more prominently convoluted shape than the MNT, comprising an up-sloping INT border, a transition angle, and a down-sloping INT border. In contrast, the CNM-atrium-MNM tract is more straightforward. Therefore, nasal anesthesia, either by the cotton-tipped applicator method [@JR223-14], gauze pledgetting [@JR223-15] or the Japanese catheter method [@JR223-21], most often targets the unswerving MNM route. The anatomy may also explain why the majority of cases of epistaxis (78 %) reported by Mori et al occurred in the MNM [@JR223-18].

Endoscopically the superior nasal turbinate and its meatus are hardly seen, and thus, have been called the forgotten turbinate [@JR223-22]. Similarly, most endoscopists recognize the INM and MNM but are ignorant of the CNM. With anterior meatuscopy, we have found that the CNM is wider at the INT level than that at the MNT level. Most importantly, we found that endoscope insertion and exertion through an endoscopically patent CNM (grade III), if pre-confirmed by anterior meatuscopy, may avoid epistaxis and nasal pain, and minimize nasal discharge.

We perform anterior meatuscopy before transnasal endoscopy but it is also suitable for transnasal laryngoscopy, esophagoscopy, endoscopic surgery, and bronchoscopy. Anterior meatuscopy should be performed prior to these transnasal endoscopic procedures because nasonasal reflexes and the physiological nasal cycle may influence meatus patency on either side of the nasal cavity from time to time [@JR223-23]. In our study, the EMSS frequencies of the INM and MNM (grade I \> II \> III \> 0) and that of the anterior CNM (grade II \> I \> 0 \> III) were found to be heterogeneous and variable. However, with EMSS, we have found that most of our patients have narrow meatuses (grades I\~II). Thus in Taiwanese and probably in all Asian patients, the predominance of low-grade EMSS justifies anterior meatuscopy before UT-EGD for selection of the most patent meatus and administration of meticulous nasal anesthesia.

Meatuscopy is a simple procedure that can be used on patients of different races, especially those with narrow nasal tracts. In the future, it may serve as a more objective measure of meatus patency before any transnasal endoscopic procedure than a sniff test. As anterior meatuscopy gains in popularity, the role of the sniff test may become diminished. The purpose of "sniff" will not be as a "test" for selecting the nostril but for inhaling decongestants and anesthetics before UT-EGD.

Although ours was a retrospective study, the large number of cases may make the data representative for Asian patients. The meatuscopic findings, such as the most safety route in the CNM, endoscope clamp in the MNM, and the parabolic route in the INM, are noteworthy observations found by successive anterior meatuscopy. These novel concepts may make transnasal endoscopy more understandable and attractive to many endoscopists. This is the first epidemiologic study to reveal the patency scores of the INM, CNM, and MNM. However, more studies are needed to further elucidate the usefulness of anterior meatuscopy before UT-EGD in Western and European countries. In conclusion, a sniff test is not reliable whereas anterior meatuscopy can be used to objectively select the most patent meatus insertion site to avoid complications. Endoscope passage through the endoscopically patent CNM, if pre-evaluated by anterior meatuscopy, may avoid epistaxis and nasal pain, and minimize nasal discharge.
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